Drug Trial Radar · NCT00115063
LOSS- Louisiana Obese Subjects Study
Last checked: Nov 20, 2026Latest source record: Feb 22, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
390
Actual
Start
Jul 2005
Primary completion
Dec 2007
Study completion Jan 2008
Sponsor
- Lead sponsor
- Pennington Biomedical Research CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Louisiana Office of Group Benefits
- First posted
- Jun 21, 2005
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 20 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
LOSS is a pragmatic clinical evaluation of intensive medical approaches to weight loss for individuals with extreme obesity (body mass index \[BMI\] 40-60 kg/m2). The intensive medical treatment is designed to produce 25% weight loss from baseline and to maintain at least 20% weight loss from baseline. The intensive medical treatment is compared to a usual care treatment model where individuals utilize self directed approaches to weight loss. The active treatment period is three years, followed by two years of observation.
Conditions
- Obesity
Interventions
group sessionsBehavioral
group sessions lead by a trained primary care clinic employee
sibutramine, orlistat, diethylpropionDrug
dosage modified according to package insert instructions at discretion of primary care physicians
Low Calorie Diet, Health OneBehavioral
liquid diet for 8-12 weeks to induce weight loss
Intensive Medical Combination Therapy for ObesityOther
Very Low Calorie Liquid diet, Group Behavioral Therapy, Meal Replacement Therapy, Obesity Pharmacotherapy and a "Treatment Toolbox".
Control ConditionOther
Access to the Mayo Clinic weight management website and usual care from the primary care physician
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change From Baseline WeightTime frame: Baseline, 2 years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Pennington Management of Clinical Trials
Baton Rouge, Louisiana
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.